News
ICViewExpert PerspectivesMedical World NewsPathogen PlaybookVideosWebinars
Conference CoverageConference ListingAPIC Chapters
Infection Control TodaySupplements And Featured Publications
CME/CEEditorial Advisory BoardJob BoardPartnersSponsoredWhitepapers
Subscribe
Educator of the Year Official Rules2024 Educator of the Year Winner2023 Educator of the Year WinnerEducator of the Year
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • IC Trends
  • Bug of the Month
  • Featured Articles
  • Featured Columns
  • Pathogen Playbook
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental ServicesEnvironmental Services
HAIs
Hand Hygiene
IC Trends
Long-Term CareLong-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Policy
PreventionPreventionPreventionPrevention
Sterile ProcessingSterile Processing
Surface Disinfection
Vascular Access
    • News
    • Subscribe
Advertisement

One-Third of Children Up to Age 3 Exposed to Zika In-Utero Have Neurological Problems

July 10, 2019
Article

New UCLA-led research suggests that 32 percent of children up to the age of 3 years who were exposed to the Zika virus during the mother’s pregnancy had below-average neurological development.

The study also found that fewer than 4 percent of 216 children evaluated had microcephaly -a smaller-than-normal head that is one of the hallmarks of the mosquito-borne disease. The heads of two of those children grew to normal size over time, the researchers reported.

The study was published in the journal Nature Medicine.

The findings, conducted by UCLA researchers with colleagues in Rio de Janeiro, Brazil, where the disease was first detected, as well as in Austria and Germany, are a follow-up to previous research. That study showed substantial neurologic damage identified through developmental testing and neuroimaging in children younger than age 2 whose mothers were infected with Zika during their pregnancies.

“Children who were exposed to Zika during their mothers’ pregnancy need to have developmental assessments over time, and eye and hearing exams should be performed,” said the study’s lead author, Dr. Karin Nielsen-Saines, a professor of clinical pediatrics in the division of pediatric infectious diseases at the David Geffen School of Medicine at UCLA and at UCLA Mattel Children’s Hospital. “If there is risk of developmental delay, or developmental delay is identified, there are cognitive, language and behavior interventions that can be put in place to improve outcomes for these children.”

The researchers tested 146 children using the Bayley-III test, an extended neurodevelopmental assessment that checks language, cognitive and motor development. They used the Hammersmith Infant Neurologic Evaluation, or HINE, a less detailed assessment, on the 70 other children whose parents did not wish to take their children in for the lengthy Bayley-III.

The researchers found that in the Bayley-III group, 51 children tested for language, 14   tested for cognitive development, and 24 evaluated for motor development scored below average.

Of the HINE group, three children had abnormal results and 67 showed normal results.

In addition, 10 of 137 children who had eye exams showed abnormal results and 14 of 114 children who underwent auditory checks had hearing deficits.

Two children in the study had normal head measurements at birth, but developed microcephaly during their first year, while two others with microcephaly at the time of birth went on to develop normal head circumference by age 1.

“This means that microcephaly is not necessarily static,” Nielsen-Saines said.

The researchers did not have a comparison group of non-Zika-exposed children born at the same time and raised in the same environment as those known to have been exposed to Zika in-utero.

“Zika exposure can be a very difficult condition to diagnose in retrospect, so we can’t rule out undiagnosed Zika infection in a control group of children enrolled at the same time,” Nielsen-Saines said. “Neurodevelopmental tests should be done simultaneously in similar populations with the same background.”

Nielsen-Saines noted that proper long-term follow-up of children whose mothers had Zika infection in pregnancy is necessary.

“These children require close attention and ongoing surveillance, so that prompt interventions to improve their development can be provided if needed,” she said.

Study co-authors are Tara Kerin, Dr. Irena Tsui, Dr. Kristina Adachi, Dr. James Cherry, and Genhong Cheng, all of UCLA; and other researchers from California, Austria, Brazil and Germany. The journal article contains the full list.

The study was funded by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases, the National Eye Institute, the Thrasher Research Fund, the Bill and Melinda Gates Foundation, the United Kingdom’s Department for International Development, ZikaPlan (Preparedness Latin American Network) and other sources in Brazil and France.

Source: University of California, Los Angeles (UCLA)


 

Recent Videos
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Concept images of Far-UVC  (Adobe Stock 316993517 by hopenv)
Physicians Sound Alarm: Vaccine Misinformation and Policy Failures Threaten US Public Health
Anna Castillo-Gutierrez, CRCST, CSPDT, CHL, CIS, CFER,  and Maya Luera, CRCST, CIS, CER, CHL
Related Content

Antimicrobial and Diagnostic Stewardship at APIC25

From Contamination to Clarity: Leveraging Urine Culture Review for Antimicrobial and Diagnostic Stewardship

Tori Whitacre Martonicz
June 18th 2025
Article

A hospital’s surveillance validation process uncovered a hidden threat to antimicrobial stewardship: contaminated urine cultures leading to unnecessary antibiotic prescriptions. This prompted a collaborative effort to improve specimen integrity and reduce inappropriate antimicrobial use through targeted diagnostic stewardship.


APIC Heroes at APIC25

APIC Salutes 2025 Trailblazers in Infection Prevention and Control

Tori Whitacre Martonicz
June 18th 2025
Article

From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.


Increasing Middle Eastern Certified IPs at APIC25

Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story

Tori Whitacre Martonicz
June 17th 2025
Article

Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.


Manufacturers's Instructions for Use at APIC25

Streamlined IFU Access Boosts Infection Control and Staff Efficiency

Tori Whitacre Martonicz
June 17th 2025
Article

A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.


Getting Ahead of Measles at APIC25

Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge

Tori Whitacre Martonicz
June 17th 2025
Article

When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.


CAUTI Prevention at APIC25

Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline

Tori Whitacre Martonicz
June 16th 2025
Article

A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.

Related Content

Antimicrobial and Diagnostic Stewardship at APIC25

From Contamination to Clarity: Leveraging Urine Culture Review for Antimicrobial and Diagnostic Stewardship

Tori Whitacre Martonicz
June 18th 2025
Article

A hospital’s surveillance validation process uncovered a hidden threat to antimicrobial stewardship: contaminated urine cultures leading to unnecessary antibiotic prescriptions. This prompted a collaborative effort to improve specimen integrity and reduce inappropriate antimicrobial use through targeted diagnostic stewardship.


APIC Heroes at APIC25

APIC Salutes 2025 Trailblazers in Infection Prevention and Control

Tori Whitacre Martonicz
June 18th 2025
Article

From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.


Increasing Middle Eastern Certified IPs at APIC25

Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story

Tori Whitacre Martonicz
June 17th 2025
Article

Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.


Manufacturers's Instructions for Use at APIC25

Streamlined IFU Access Boosts Infection Control and Staff Efficiency

Tori Whitacre Martonicz
June 17th 2025
Article

A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.


Getting Ahead of Measles at APIC25

Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge

Tori Whitacre Martonicz
June 17th 2025
Article

When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.


CAUTI Prevention at APIC25

Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline

Tori Whitacre Martonicz
June 16th 2025
Article

A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.

Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News